[Dopamine in patients with cardiogenic shock (author's transl)].
The effect of dopamine was tested in 20 patients with cardiogenic shock. 14 patients suffered from acute myocardial infarction, 6 patients from severe heart failure. In the beginning the dosis of dopamine was 200 to 300 microgram/min. 4 patients with an acute myocardial infarction died in shock. The remaining 10 patients survived the first shock symptomes. All patients with heart failure survived the cardiogenic shock. Hemodynamic studies showed a sigificant increase of the arterial mean pressure and a decrease of the diastolic arterial pulmonary pressure. During dopamine a statistically not significant increase of cardiac index and stroke volume was observed.
D000368:Aged; D001794:Blood Pressure; D002302:Cardiac Output; D002986:Clinical Trials as Topic; D004298:Dopamine / Q000008:administration & dosage / Q000627:therapeutic use*; D004341:Drug Evaluation; D006333:Heart Failure / Q000150:complications; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D011651:Pulmonary Artery; D012770:Shock, Cardiogenic / Q000150:complications / Q000188:drug therapy*
D004298:Dopamine
Dopamin beim kardiogenen Schock.